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Background
Chronic use of high doses of benzodiazepines may lead to
development of tolerance and dependence. Long-term
administration of diazepam causes CNS changes: signifi-
cantly increased amount of GABA required for neuronal
activity inhibition; reduced efficacy of diazepam on
GABA-evoked Cl- currents [1]; functional changes in the
chloride channel related to withdrawal signs [2]; changes
in glutamate receptors [3]. Our previous data showed that
anthocyanins diminished diazepam toxicity and signifi-
cantly enhanced the survival of mice, treated with lethal
doses of diazepam. Anthocyanins are naturally occurring
flavonoids with various pharmacological activities. Litera-
ture data determine flavonoids as benzodiazepine recep-
tor ligands [4]. We estimated withdrawal signs in the
experimental rats in order to evaluate the effects of
anthocyanins on diazepam dependence.
Materials and methods
Wistar rats were divided into three groups: I - diazepam; II
- diazepam + anthocyanins 100 mg/kg; III - diazepam +
anthocyanins 200 mg/kg. Rats were treated for 60 days.
We evaluated fast breathing, hypermotility, seizures,
tremor and piloerection as withdrawal signs after discon-
tinuation of diazepam.
Results
Our results showed that the administration of anthocy-
anins significantly decreased abstinent signs of diazepam
dependent rats. The most prominent effects were
observed in the “diazepam + anthocyanins 200 mg/kg”
group.
Conclusions
Anthocyanins administered together with diazepam are
able to diminish diazepam dependence and can be used
preventively in cases that require chronic therapy with
benzodiazepines.
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